Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver profile. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established
Over a 9-year period, 58 patients who had previous portasystemic shunt procedures underwent orthotop...
Acute veno-occlusive disease of the liver developed in seven of 29 patients undergoing bone marrow t...
BACKGROUND: Transjugular intrahepatic portosystemic shunting (TIPS) has become an effective treatmen...
Hepatic veno-occlusive disease is a clinical syndrome characterized by hepatomegaly, ascites, weight...
Veno-occlusive disease (VOD) of the liver occurs in 10% to 50% of patients after hematopoietic stem ...
The occurrence of hepatic veno-occlusive disease (VOD) has been reported in up to 60% of patients fo...
Azathioprine-induced veno-occlusive disease of the liver mainly described after kidney transplantati...
Veno-occlusive disease (VOD) of the liver is a severe complication of high-dose chemotherapy and all...
• Objective: To determine the incidence and clinical course of veno-occlusive disease of the liver (...
Hepatic veno-occlusive disease (VOD) remains one of the commonest and most serious complications aft...
Veno-occlusive disease (VOD) is a common, early com-plication of bone marrow transplantation (BMT). ...
A 38-year-old man with a non-Hodgkin's lymphoma of intermediate grade malignancy attained partial re...
To determine the incidence and outcome of hepatic veno-occlusive disease (VOD) after blood or marrow...
Balloon-occluded retrograde transvenous obliteration (BRTO) has become a common and effective proced...
Abstract Background Budd-Chiari syndrome (BCS) generally implies thrombosis of the hepatic veins and...
Over a 9-year period, 58 patients who had previous portasystemic shunt procedures underwent orthotop...
Acute veno-occlusive disease of the liver developed in seven of 29 patients undergoing bone marrow t...
BACKGROUND: Transjugular intrahepatic portosystemic shunting (TIPS) has become an effective treatmen...
Hepatic veno-occlusive disease is a clinical syndrome characterized by hepatomegaly, ascites, weight...
Veno-occlusive disease (VOD) of the liver occurs in 10% to 50% of patients after hematopoietic stem ...
The occurrence of hepatic veno-occlusive disease (VOD) has been reported in up to 60% of patients fo...
Azathioprine-induced veno-occlusive disease of the liver mainly described after kidney transplantati...
Veno-occlusive disease (VOD) of the liver is a severe complication of high-dose chemotherapy and all...
• Objective: To determine the incidence and clinical course of veno-occlusive disease of the liver (...
Hepatic veno-occlusive disease (VOD) remains one of the commonest and most serious complications aft...
Veno-occlusive disease (VOD) is a common, early com-plication of bone marrow transplantation (BMT). ...
A 38-year-old man with a non-Hodgkin's lymphoma of intermediate grade malignancy attained partial re...
To determine the incidence and outcome of hepatic veno-occlusive disease (VOD) after blood or marrow...
Balloon-occluded retrograde transvenous obliteration (BRTO) has become a common and effective proced...
Abstract Background Budd-Chiari syndrome (BCS) generally implies thrombosis of the hepatic veins and...
Over a 9-year period, 58 patients who had previous portasystemic shunt procedures underwent orthotop...
Acute veno-occlusive disease of the liver developed in seven of 29 patients undergoing bone marrow t...
BACKGROUND: Transjugular intrahepatic portosystemic shunting (TIPS) has become an effective treatmen...